Diabetes Mellitus Type 2 Perspective

 
 
  • ENDO 2019 Read clinically focused news coverage of key developments from ENDO 2019
  • Amputations in Diabetes Back on the Rise, but Why? After a steady decline in rates of amputation in patients with diabetes, a new study shows that rates are increasing, with few obvious explanations as to why.
  • Renal Benefits of SGLT2s and GLP1s   Drs Jay Shubrook and Katherine Tuttle discuss trial results that may provide new options for patients with diabetes and chronic kidney disease.
  • Broken PROMISE: CTA for Suspected CAD in Patients With Diabetes A flawed post hoc analysis was critiqued on social media, but why didn't peer review catch the weaknesses, asks John Mandrola, MD.
  • Implications of the T2DM-CVD-CKD Link: What We've Learned   Drs Jay Shubrook and Katherine Tuttle discuss current understanding of these important links and implications for screening and detection.
  • DUPC 2019 Read clinically focused news coverage of key developments from DUPC 2018
  • Stop the Patient Blame Game: What Actually Causes Obesity? Is it a lack of willpower? Are people choosing to overeat? Dr Dhurandhar reviews the most common misperceptions about obesity and discusses some of its real causes.
  • Are Web-Based Depression Interventions Cost-Effective?   The cost-effectiveness of a Web-based intervention: Dr Peter Yellowlees discusses recent results for individuals with diabetes and comorbid depression.
  • Statin Deprescribing Follow-up: How You Voted Did readers agree with Dr Vega on whether to deprescribe an elderly patient's statin?
  • Addressing CV Risk: What Clinicians Told Us Outcomes of CV risk factor management survey highlight the importance of addressing diet and lifestyle, diabetes treatment, and hypertension, as well as barriers to these considerations.
  • A Guide to Improving Insulin Access for Patients With T1D Dr Tridgell is an active advocate for affordable access to insulin. Here, he lays out concrete steps clinicians can take to improve insulin access for patients with type 1 diabetes.
  • Antioxidants for Pediatric NAFLD Can a simple phenol of extra virgin olive oil given with vitamin E improve NAFLD in children?
  • Deintensifying Diabetes Drugs: Important Considerations Much attention has been paid to when to increase intensity of antidiabetes medications. But when should you step back -- and in which patients?
  • 8 Ways to Compete Successfully With Retail Clinics Primary care patients are often attracted to retail-based clinics, which exist in most urban areas. There are helpful ways that medical practices can keep these patients within their practice.
  • Contraception for Women With Chronic Medical Conditions   A new practice bulletin from ACOG guides individualized decision-making about contraception for women with chronic medical conditions.
  • The Other Nutrition Crisis By getting to the bottom of what is causing malnutrition in older adults, clinicians can help these patients live healthier, happier lives.
  • Cardiology Topics to Watch for in 2019 Wearables, aspirin for secondary prevention, AI and machine learning, and drug pricing are among the topics to keep an eye on in 2019, according to cardiologists Drs Harrington and Gibson.
  • The Loneliness of Being a Physician Despite seeing patients, families, and colleagues for hours daily, a physician's job can be lonely. One doctor talks about what's needed to overcome this.
  • Choosing a First Injectable in Type 2 Diabetes: Try a GLP-1   The new ADA/EASD guidelines suggest major changes in the way we manage patients with T2D. Drs Shubrook and Skolnik focus on new information about the GLP-1 receptor agonists, why to use them, and how to choose which to use.
  • Generic DPP-4 Inhibitors Would Be a 'Shot in the Arm' Dr Akshay Jain discusses the potential implications of a generic DPP-4 inhibitor for the management of type 2 diabetes that may soon enter the US market.